Stereotaxis, Inc.
AMEX:STXSMedical - Instruments & Supplies
+$0.05 today
- Market cap
- $94.80M
- Beta
- 1.32
- P/E (TTM)
- -8.3
- EPS (TTM)
- -$0.22
Volume 0.90M
Average 0.39M
STXS Operating Income
Profit from core operations after operating expenses, before interest and taxes.
Stereotaxis, Inc.AMEX: STXS
Operating Income · Q1 FY2026 · quarter ended Mar 2026
Operating income remains negative
Q1 FY2026 operating income was -$5.18M, compared with -$5.93M a year earlier. Trailing-twelve-month operating income was -$21.36M.
Context
- Operating income amounted to 68.3% of revenue in FY2025, down 23.6 pp from a year earlier.
- Operating income grew in size in 2 of the last 3 fiscal years.
What to watch
Whether operating income reaches the consensus estimate from 2 analysts of -$20.62M (+6.8%) for the fiscal year ending Dec 2026, a slowdown from the +10.6% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$5.18M+8.3% QoQ
- Last fiscal yearDec 2025
- -$22.11M+10.6% YoY
- LTMMar 2026
- -$21.36M+17.6% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +12.6% | -28.9% | -41.5 pp |
| 1 year | +10.6% | +6.8% | -3.9 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Operating Income history
USD · from the income statement
- Latest · FY2025
- (22.11M) USD
- Year-over-year change
- +10.6%
| Period | Period end | Operating Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (22.11M) | +10.6% |
| FY2024 | 2024-12-31 | (24.74M) | -13.3% |
| FY2023 | 2023-12-31 | (21.84M) | -16.3% |
| FY2022 | 2022-12-31 | (18.78M) | -45.7% |
| FY2021 | 2021-12-31 | (12.89M) | — |
Operating Income vs competitors
How STXS compares with its peers on the latest reported figures
- STXS's LTM Mar 2026 operating income of -$21.36M is the 4th highest of the 5 companies compared; the peer median is -$16.4M.
- Its year-over-year change of +17.6% is the 2nd highest of 5, against a peer median of -4.6%.
- Operating income amounts to 68.5% of revenue for STXS, versus a peer median of 41.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | -$6.13M | +68.6% | — | 12.7% | |
| LTM Mar 2026 | -$16.04M | -30.8% | — | 15278.1% | |
| LTM Mar 2026 | -$16.76M | +13.0% | — | 16.8% | |
| LTM Mar 2026 | -$21.36M | +17.6% | — | 68.5% | |
| LTM Mar 2026 | -$26.48M | -22.1% | — | 65.2% | |
| Peer median (excluding STXS) | -$16.4M | -4.6% | — | 41.0% | |
Competitors are the stored peer set for STXS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 35.02M | 28.15M | 26.77M | 26.92M | 32.38M |
| Cost of Revenue | 11.79M | 9.68M | 11.91M | 12.32M | 15.31M |
| Gross Profit | 23.23M | 18.47M | 14.86M | 14.59M | 17.07M |
| Gross Margin | 66.3% | 65.6% | 55.5% | 54.2% | 52.7% |
| Research & Development | 10.2M | 10.56M | 10.27M | 9.76M | 9.38M |
| Selling, General & Admin | 25.92M | 26.69M | 26.43M | 29.57M | 30.29M |
| Operating Expenses | 36.12M | 37.25M | 36.7M | 39.33M | 39.18M |
| Depreciation & Amortization | 106K | 429K | 595K | 969K | 1.56M |
| EBITDA | (10.6M) | (17.86M) | (20.12M) | (23.08M) | (20.09M) |
| EBITDA Margin | -30.3% | -63.5% | -75.1% | -85.7% | -62.0% |
| Operating Income | (12.89M) | (18.78M) | (21.84M) | (24.74M) | (22.11M) |
| Operating Margin | -36.8% | -66.7% | -81.6% | -91.9% | -68.3% |
| Interest Income | 0 | 484K | 1.1M | 694K | 467K |
| Interest Expense | 10.07K | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 2.17M | 484K | 1.13M | 694K | 469K |
| Income Before Tax | (10.72M) | (18.29M) | (20.71M) | (24.05M) | (21.64M) |
| Pre-Tax Margin | -30.6% | -65.0% | -77.4% | -89.3% | -66.8% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (10.72M) | (18.29M) | (20.71M) | (24.05M) | (21.64M) |
| Net Margin | -30.6% | -65.0% | -77.4% | -89.3% | -66.8% |
| EPS (Basic) | (0.16) | (0.26) | (0.27) | (0.30) | (0.25) |
| EPS (Diluted) | (0.16) | (0.26) | (0.27) | (0.30) | (0.25) |
| Weighted Avg Shares | 75.56M | 76.06M | 80.7M | 85.18M | 90.96M |
| Weighted Avg Shares (Diluted) | 75.56M | 76.06M | 80.7M | 85.18M | 90.96M |
Stereotaxis, Inc.
AMEX:STXS
Intrinsic Alpha fair value
Locked
Current Price
$0.95
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.